Back to search

Article

Clioquinol improves catalytic activity of PHGDH and shows antiseizure efficacy in patients

2024-10-01

Abstract excerpt

Drug-resistant epilepsy (DRE) affects over 25 million people worldwide and is associated with neuroinflammation. We identified haloquinolines from a drug repurposing library as potent activators of phosphoglycerate dehydrogenase (PHGDH) enzyme, which converts 3-phosphoglycerate to generate serine and the neurotransmitter glycine, and steers anti-inflammatory responses. The most promising haloquinoline clioquinol c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a5e33ef8-63c7-5866-a3d3-ef4134348ded
DOI
10.1101/2024.09.28.24314470
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clioquinol improves catalytic activity of PHGDH and shows antiseizure efficacy in patientsDOI 10.1101/2024.09.28.24314470
Select a neighboring publication to make it the new centre.